Endothelial Bmp6 conditional knockout mice exhibit hemochromatosis, whereas hepatocyte and macrophage Bmp6 conditional knockout mice do not.
Our data support a model in which EC Bmp6 has paracrine actions on hepatocyte hemojuvelin to regulate hepcidin production.
Bone morphogenetic protein 6 (BMP6) signaling in hepatocytes is a central transcriptional regulator of the iron hormone hepcidin that controls systemic iron balance. How iron levels are sensed to regulate hepcidin production is not known, but local induction of liver BMP6 expression by iron is proposed to have a critical role. To identify the cellular source of BMP6 responsible for hepcidin and iron homeostasis regulation, we generated mice with tissue-specific ablation of Bmp6 in different liver cell populations and evaluated their iron phenotype. Efficiency and specificity of Cre-mediated recombination was assessed by using Cre-reporter mice, polymerase chain reaction of genomic DNA, and quantitation of Bmp6 messenger RNA expression from isolated liver cell populations. Localization of the BMP co-receptor hemojuvelin was visualized by immunofluorescence microscopy. Analysis of the Bmp6 conditional knockout mice revealed that liver endothelial cells (ECs) expressed Bmp6, whereas resident liver macrophages (Kupffer cells) and hepatocytes did not. Loss of Bmp6 in ECs recapitulated the hemochromatosis phenotype of global Bmp6 knockout mice, whereas hepatocyte and macrophage Bmp6 conditional knockout mice exhibited no iron phenotype. Hemojuvelin was localized on the hepatocyte sinusoidal membrane immediately adjacent to Bmp6-producing sinusoidal ECs. Together, these data demonstrate that ECs are the predominant source of BMP6 in the liver and support a model in which EC BMP6 has paracrine actions on hepatocyte hemojuvelin to regulate hepcidin transcription and maintain systemic iron homeostasis.
Iron homeostasis is tightly controlled to ensure sufficient iron for erythropoiesis and other fundamental metabolic processes and to prevent the toxicity of excess iron.1 The peptide hormone hepcidin is a master regulator of systemic iron balance by mediating the degradation of the iron export protein ferroportin to limit dietary iron absorption and macrophage iron recycling.2 Hepcidin production in the liver is carefully titrated in response to changes in organismal iron content and iron utilization requirements.1 Failure to appropriately induce hepcidin in response to iron is a central feature of hereditary hemochromatosis, a genetic disorder characterized by excess iron deposits in the liver, heart, and endocrine glands, resulting in organ dysfunction.3 The most severe juvenile-onset form of this disease is caused by mutations in the genes encoding hepcidin itself (HAMP) or hemojuvelin (HFE2, also known as HJV), which regulates hepcidin transcription in hepatocytes.4,5 Mice with global or hepatocyte-specific deletion of these genes have a similar iron overload phenotype,6-11 confirming the essential role of hepatocyte hepcidin production regulated by HJV in controlling systemic iron balance.
HJV regulates hepcidin by functioning as a co-receptor for the BMP signaling pathway,12 which activates hepcidin transcription via specific SMAD-binding elements on the hepcidin promoter.13 BMP6 is a key endogenous ligand for HJV to regulate hepcidin transcription and systemic iron balance because global Bmp6−/− mice exhibit an iron overload phenotype similar to that of Hjv−/− mice.14,15 Moreover, heterozygous mutations in the BMP6 prodomain were recently linked to inappropriately low hepcidin levels and iron overload in humans.16 Notably, liver Bmp6 messenger RNA (mRNA) expression is regulated by dietary iron and correlates with liver iron content in mice, whereas Bmp6 expression is not altered by iron in other tissues.17-21 In addition, a neutralizing BMP6 antibody blunts hepcidin induction by a high iron diet, resulting in increased accumulation of tissue iron in mice.18 Thus, regulation of liver BMP6 mRNA expression is a critical mechanism by which iron levels regulate hepcidin.
How iron levels are sensed by the liver to control BMP6 production remains unknown. Liver cell isolation experiments suggest that nonparenchymal cells (NPCs), including sinusoidal endothelial cells (SECs), Kupffer cells (KCs), and hepatic stellate cells (HSCs) rather than hepatocytes, are the predominant source of BMP6 in the liver.22-24 However, Bmp6 mRNA and protein were reported to be induced by iron in hepatocytes.19,24,25 Importantly, functional data are lacking that demonstrate which liver cell population is the main source of BMP6 that is crucial for maintaining systemic iron balance. To answer this fundamental question, we generated mice with a conditional knockout of Bmp6 in different liver cell populations.
Animal protocols were approved by the Institutional Animal Care and Use Committee at Massachusetts General Hospital. Embryonic stem (ES) cells from 129SvEv mice expressing a Bmp6 floxed allele (Figure 1A) were purchased from Mutant Mouse Resource and Research Center (Lexicon 1E10, 029763-UCD). ES cells were injected into C57BL/6 blastocysts to generate chimeric mice by the Beth Israel Deaconess Transgenic Core Facility. Chimeric mice were mated with C57BL/6 mice to generate F1 heterozygotes, which were intercrossed to generate littermate Bmp6+/+ (wild-type), Bmp6fl/+, and Bmp6fl/fl (Bmp6 floxed) mice.
To generate global Bmp6 knockout (Bmp6−/−) mice, Bmp6fl/fl mice were mated with mice expressing Cre recombinase under a global cytomegalovirus (CMV) promoter (B6.C-Tg(CMV-cre)1Cgn/J; The Jackson Laboratory). Bmp6+/−;CMV-Cre+ offspring were crossed with C57BL/6 mice to ensure germline transmission and remove the Cre. Bmp6+/− offspring were intercrossed to generate littermate Bmp6+/+, Bmp6+/−, and Bmp6−/− mice.
To generate conditional Bmp6 knockout (Bmp6fl/fl;Cre+) mice, Bmp6fl/fl mice were crossed with mice (The Jackson Laboratory) expressing Cre recombinase under the control of an albumin promoter/enhancer (B6.Cg-Tg(Alb-cre)21Mgn/J, hereafter Alb-Cre), receptor tyrosine kinase Tek (Tie2) promoter/enhancer (B6.Cg-Tg(Tek-cre)1Ywa/J, hereafter Tek-Cre), or lysozyme 2 gene (Lyz2) promoter/enhancer elements (B6.129P2-Lyz2tm1(cre)Ifo/J, hereafter LysM-Cre). Efficiency and specificity of Cre-mediated recombination was assessed by mating Alb-Cre, Tek-Cre, and LysM-Cre mice with Cre-reporter mice (B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Jackson, hereafter Rosa26tdT) that express tandem dTomato (tdT) in Cre+ cells because of removal of a LoxP-flanked stop cassette.
All mice were maintained on a mixed C57BL/6,129SvEv background with ad libitum access to water and a Prolab 5P75 Isopro RMH 3000 diet containing 380 ppm iron. Mice were genotyped by polymerase chain reaction (PCR) of genomic DNA extracted from the tail and from isolated liver cell populations using a DNeasy Blood Tissue Kit (Qiagen) and primers listed in supplemental Table 1, available on the Blood Web site. Age- and sex-matched littermate Bmp6+/+ or Bmp6fl/fl;Cre– mice were used as controls throughout the study. Numbers, sex, and ages of mice used in experiments are listed in supplemental Table 2.
Liver sections were fixed, cryosectioned, and stained with anti-CD31, anti-F4/80, anti-desmin, and anti-HJV antibodies as detailed in the supplemental Methods. Images were acquired by using a Nikon A1R confocal laser scanning microscope. TIFF files were imported into Adobe Photoshop, and the entire field was enhanced and sharpened by using the levels command and/or high-pass filter. Recombination efficiency was quantitated by counting the percent of hepatocytes, KCs, and SECs (determined by morphology, F4/80, or CD31 staining, respectively) that were tdT positive in Rosa26tdT;Alb-Cre-, LysM-Cre-, and Tek-Cre-reporter mice. In all, 325 to 1000 cells were counted in 4 mice per group.
Hepatocyte and NPC isolation
Livers were perfused via the inferior vena cava with KRH (115 mM NaCl, 5 mM KCl, 1 mM KH2PO4, 25 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid [pH 7.4]) containing 0.02% EGTA at 5 mL/min for 7 minutes, followed by 0.005% collagenase (Sigma-Aldrich), 1 mM CaCl2, and 2.5 mM MgSO4 in KRH for 6 minutes. Cells were filtered through a 70-μm cell strainer and centrifuged at 50 rcf for 4 minutes. The supernatant was centrifuged at 750 rcf for 5 minutes to collect NPCs, and pellets were resuspended in KRH and centrifuged in a 50% Percoll gradient (GE Healthcare) at 50 rcf for 10 minutes to collect viable hepatocytes.
KC and endothelial cell isolation
NPC supernatants collected as above were filtered through a 40-μm cell strainer, centrifuged at 750 rcf for 5 minutes, and treated with red blood cell lysis buffer (BioLegend). Cell pellets were resuspended and stained in phosphate-buffered saline containing 1% fetal bovine serum and 0.5% bovine serum albumin using antibodies listed in supplemental Table 3. KCs and endothelial cells (ECs; composed mainly of SECs) were isolated by fluorescence-activated cell sorting (FACS) using a FACSAria II (BD Biosciences). Cells were first gated using forward scatter and side scatter characteristics, and doublets were sequentially excluded by comparing foward scatter and side scatter height and area signals. ECs were identified as CD326–, CD45–, CD31+, CD146+. KCs were defined as CD326–, CD31–, CD45+, Lin–, F4/80high, CD11bint, CD64+, MHC-II+, after separation from lineage-positive leukocytes (CD3e, CD19, CD90.2, Ly6G, NK1.1) and monocytes (CD326–, CD31–, CD45+, Lin–, F4/80low, CD11b+, CD64– Ly-6C+). For purity checks, sorted cell populations were run on an LSRII flow cytometer (BD Biosciences), and data were analyzed with FlowJo v8.8.6 software (Tree Star).
RNA isolation and quantitative real-time reverse transcription PCR
Total liver RNA was isolated by using QIAshredder and RNeasy purification kits (Qiagen), and complementary DNA (cDNA) was synthesized from 1000 ng RNA by using the iScript cDNA synthesis kit (Bio-Rad). For isolated liver cell populations, RNA was extracted with the PicoPure RNA Isolation Kit (Thermo Scientific), RNA concentration was measured with an RNA 6000 Pico Kit and 2100 Bioanalyzer (Agilent), and cDNA was synthesized from 1000 pg RNA by using the SuperScript VILO cDNA Synthesis Kit (Invitrogen) according to the manufacturers’ instructions. Quantitative real-time PCR was performed as described previously26 by using the Power SYBR Green PCR Master Mix (Life Technologies) and primers listed in supplemental Table 4. Results are reported as mean ± standard error of the mean using the formula –ΔCt = –[Ct target gene – Ct control gene Rpl19], with a higher –ΔCt indicating higher mRNA expression. Fold change is derived from 2–ΔΔCt where ΔΔCt = ΔCt higher expressing group – ΔCt lower expressing group.
Serum iron, transferrin saturation, and tissue nonheme iron concentrations were determined as described previously.26 Tissue iron is reported as micrograms of iron per gram of wet weight tissue.
Prussian blue staining
Tissues were fixed in neutral buffered formalin for 24 hours, embedded in paraffin, sectioned at 7 μm, deparaffinized and rehydrated, and subjected to Perls’ Prussian blue staining by using an iron stain kit (American MasterTech). For tissues with less iron loading, a modified diaminobenzidine-enhanced Perls’ stain containing cobalt chloride was used.27
Statistical significance was determined by two-tailed Student t test or one-way analysis of variance (ANOVA) with Dunnett’s or Tukey’s post hoc test for pairwise multiple comparisons using Prism 7 (GraphPad). P < .05 was considered significant.
Generation of Bmp6fl/fl, Bmp6−/−, and conditional Bmp6 knockout mice
Bmp6 chimeric mice were generated by injecting C57BL/6 blastocysts with 129SvEv ES cells containing a recombined Bmp6 allele with LoxP sites flanking exons 5 to 7 encoding the Bmp6 mature region (Figure 1A). Germline transmission was confirmed by PCR (Figure 1B). Bmp6fl/+ mice were intercrossed to generate littermate Bmp6fl/fl and Bmp6+/+ mice on a mixed C57BL/6,129SvEv background. Bmp6fl/fl mice exhibited iron parameters similar to that of littermate Bmp6+/+ mice without other obvious abnormalities, suggesting that the floxed allele does not impact Bmp6 function (supplemental Figure 1).
Bmp6fl/fl mice were mated with C57BL/6 mice expressing Cre recombinase under a global CMV promoter (see “Methods”) to generate littermate Bmp6+/+, Bmp6+/−, and Bmp6−/− mice on a mixed C57BL/6,129SvEv background. Genotyping showed the expected wild-type and recombined alleles (Figure 1B). qRT-PCR of liver tissue confirmed a progressive loss of Bmp6 mRNA expression in Bmp+/− and Bmp6−/− mice (Figure 1C).
To generate mice lacking Bmp6 in different liver cell populations, Bmp6fl/fl mice were mated with Alb-Cre, LysM-Cre, or Tek-Cre mice (see “Methods”), which have been widely used in the literature to generate hepatocyte, macrophage, and endothelial conditional knockout mice, respectively.28-30 HSC conditional knockout mice were not generated because of the lack of commercially available HSC-specific Cre mice. All Bmp6 conditional knockout mice (Bmp6fl/fl;Cre+) were compared with littermate Bmp6fl/fl;Cre– mice.
Efficiency and specificity of Cre-mediated recombination were evaluated by immunofluorescence microscopy of liver tissue from tdT Cre-reporter mice (Rosa26tdT) mated with each Cre strain by using antibodies against CD31, desmin, and F4/80 to identify SECs, HSCs, and KCs, respectively (Figure 2A-C). Hepatocytes were identified by cell morphology. tdT was expressed specifically in hepatocytes in Alb-Cre mice (Figure 2A) and in macrophages in LysM-Cre mice (Figure 2B), with recombination efficiencies of >99% and 98%, respectively, consistent with previous studies.31,32 In offspring from a male Tek-Cre parent, tdT was highly expressed in SECs (Figure 2C) with 98% recombination efficiency, but low-level expression was also seen in KCs (Figure 2C, inset). This is consistent with a recent report that KCs originate from Tek-expressing progenitors in the yolk sac.33 Notably, some offspring from female Tek-Cre mice exhibited germline recombination as previously reported.34 Therefore, we used only offspring from a male Tek-Cre parent for subsequent analyses.
Bmp6 recombination was evaluated by PCR of genomic DNA from isolated liver cell populations. ECs and KCs were each isolated by FACS and exhibited ≥99% purity as measured by FACS (supplemental Figure 2). qRT-PCR of Cd146, Cd45, and Tmprss6 as markers of ECs, leukocytes including KCs, and hepatocytes, respectively, confirmed that the isolated cell populations were highly enriched with ∼40- to 400-fold higher levels of the cell type–specific transcripts in the corresponding cell populations (Figure 2D-F). However, Cd146, Cd45, and Tmprss6 were still detectable in non-EC, non-KC, and nonhepatocyte fractions, respectively, suggesting some contamination of each cell population with RNA from all of the other cell types. Despite these minor impurities, PCR of genomic DNA confirmed the loss of the floxed allele and the presence of the recombined allele specifically in hepatocytes for Bmp6fl/fl;Alb-Cre+ mice (Figure 2G) and KCs for Bmp6fl/fl;LysM-Cre+ mice (Figure 2H). Bmp6fl/fl;Tek-Cre+ mice exhibited loss of the floxed allele and presence of the recombined allele in both ECs and KCs (Figure 2I).
Loss of Bmp6 mRNA expression in isolated liver cell populations was assessed by qRT-PCR. In control Bmp6fl/fl;Cre– mice, Bmp6 mRNA was much more abundant in NPCs than in hepatocytes and was predominantly expressed in ECs. (Figure 2J-L). Notably, the fold enrichment of Bmp6 mRNA in ECs relative to hepatocytes and KCs was similar to the fold enrichment of the endothelial marker Cd146 (compare Figure 2J-L,Bmp6fl/fl;Cre– mice to 2D). This suggests that the Bmp6 measured in hepatocyte and KC fractions could be the result of EC contamination. Consistent with the Cre-reporter mice and genomic DNA results, Bmp6 mRNA was strongly reduced in ECs and KCs of Bmp6fl/fl;Tek-Cre+ mice (Figure 2L). Interestingly, the relatively low Bmp6 mRNA expression was not further reduced in hepatocytes of Bmp6fl/fl;Alb-Cre+ mice (Figure 2J) or in KCs of Bmp6fl/fl;LysM-Cre+ mice (Figure 2K), despite clear Cre-mediated recombination in the Cre-reporter mice and genomic DNA analysis (Figure 2A-B,G-H). In contrast, Bmp6 mRNA expression was almost completely abolished in hepatocytes of Bmp6fl/fl;Tek-Cre+ mice (Figure 2L), despite the absence of Cre-mediated recombination in hepatocytes by Cre-reporter mice and genomic DNA analysis (Figure 2C,I). Together, these data suggest that ECs are the predominant source of BMP6 in the liver, whereas the hepatocyte and KC Bmp6 mRNA measured here and reported in other cell isolation studies22-24 is most likely an artifact of EC contamination. Importantly, although the Tek-Cre causes recombination in KCs as well as ECs (this appears to be a limitation of all endothelial models described to date), the recombination of Bmp6 in KCs is unlikely to be of functional significance.
Bmp6fl/fl;Tek-Cre+ mice exhibit hepcidin deficiency and iron overload, whereas Bmp6fl/fl;Alb-Cre+ and Bmp6fl/fl;LysM-Cre+ mice do not
A hemochromatosis phenotype was previously reported for Bmp6−/− mice generated by a different strategy that targeted exon 2.14,15 Bmp6−/− mice in this study likewise exhibited significantly reduced liver hepcidin (Hamp) mRNA (Figure 3A [red bars]), increased serum iron and transferrin saturation (Figure 3B-C [red bars]), increased liver iron (Figure 4A [compare red with magenta lines] and C; supplemental Figure 3), reduced spleen iron (Figure 4B [compare red with magenta lines] and C; supplemental Figure 3), and increased extrahepatic iron loading in pancreas and heart (Figure 5; supplemental Figure 3) compared with littermate Bmp6+/+ mice at 8 to 16 weeks of age. The Bmp6 target transcript Id1, but not Smad7, was also reduced in Bmp6−/− mice (supplemental Figure 4). Both male and female Bmp6−/− mice exhibited hemochromatosis; however, male Bmp6−/− mice seemed to have lower Hamp mRNA (Figure 3A) and greater extrahepatic iron loading compared with female Bmp6−/− mice (Figure 5), similar to a prior report.35 Heterozygous Bmp6+/− mice did not have an iron overload phenotype.
Bmp6fl/fl;Tek-Cre+ mice also exhibited significantly lower liver Bmp6 and Hamp mRNA, increased serum iron and transferrin saturation, increased liver iron, reduced spleen iron, and increased extrahepatic iron loading compared with littermate Bmp6fl/fl;Cre– mice (Figures 3 [blue bars], 4A-B, and 5A-B [compare dark blue to light blue lines], 4C, 5C; supplemental Figure 3). Similar to Bmp6−/− mice, males seemed to have greater Hamp mRNA deficiency (Figure 3A) and extrahepatic iron loading (Figure 5) compared with females. Although a comparative analysis of Bmp6−/− and Bmp6fl/fl;Tek-Cre+ mice is limited by their mixed genetic background and the inability to compare littermates, Bmp6fl/fl;Tek-Cre+ mice had detectable residual liver Bmp6 mRNA, whereas Bmp6−/− mice did not (Figure 3D). Consistent with some residual Bmp6 activity, Bmp6fl/fl;Tek-Cre+ mice tended to have higher Hamp mRNA, particularly in males, and lower extrahepatic iron loading compared with sex-matched Bmp6−/− mice (Figures 3A and 5).
In contrast, Bmp6fl/fl;LysM-Cre+ and Bmp6fl/fl;Alb-Cre+ mice had normal serum and tissue iron levels and unchanged liver Hamp and Bmp6 mRNA expression compared with littermate Bmp6fl/fl;Cre– mice, even up to 16 weeks of age (Figures 3 [green and purple bars], 4, and 5; supplemental Figure 5). Moreover, no differences were seen in Hamp mRNA induction or serum or tissue iron levels in Bmp6fl/fl;Alb-Cre+ or Bmp6fl/fl;LysM-Cre+ mice compared with Bmp6fl/fl;Cre– mice in response to a high iron diet (supplemental Figure 6). Although the high iron diet seemed to increase Bmp6 mRNA in all isolated liver cell populations, as previously reported,24 Bmp6 mRNA was still not reduced in isolated hepatocytes of Bmp6fl/fl;Alb-Cre+ or in the KCs of Bmp6fl/fl;LysM-Cre+ mice compared with Bmp6fl/fl;Cre– mice, whereas Bmp6 mRNA was reduced in all cell populations from Bmp6fl/fl;Tek-Cre+ mice (supplemental Figure 7). The relative Bmp6 mRNA expression in different liver cell populations of Bmp6fl/fl;Cre– mice continued to mirror the relative expression of the EC marker Cd146 (supplemental Figure 7). These data are consistent with the notion that measured Bmp6 mRNA in isolated hepatocytes and KCs is an artifact of EC contamination and suggest that hepatocytes and KCs do not functionally contribute to liver Bmp6 production, even in the context of iron loading. As previously reported,18-21 the induction of Bmp6 mRNA by using a high iron diet appeared to be limited to the liver because we did not detect increases in Bmp6 mRNA in other organs tested, including the heart (supplemental Figure 8).
Paracrine effects of SEC Bmp6 on hepatocyte Hjv
Finally, we examined localization of the Bmp6 co-receptor Hjv in the livers of mice expressing the tdT reporter in ECs. Hjv was predominantly expressed on the sinusoidal membrane of hepatocytes immediately adjacent to SEC membranes (Figure 6). Thus, Hjv is poised to respond to locally produced Bmp6 secreted by liver SECs to regulate hepcidin expression in hepatocytes. No significant changes were detected in Hjv protein expression or localization in Bmp6−/− compared with Bmp6+/+ mice (supplemental Figure 9).
Inability to appropriately regulate hepcidin production in response to iron loading or deficiency contributes to the pathogenesis of several iron homeostasis disorders. Regulation of liver BMP6 mRNA expression is a key mechanism by which iron levels control hepcidin expression. Here, we used mice with a conditional ablation of Bmp6 in different liver cell populations to demonstrate that ECs are the predominant source of Bmp6 critical for hepcidin and iron homeostasis regulation, whereas KCs and hepatocytes do not have a major functional role.
A central role of ECs in Bmp6 production for iron homeostasis regulation is supported by the findings of hepcidin deficiency and iron overload in Bmp6fl/fl;Tek-Cre+ mice. A complicating factor is that the Tek-Cre is not fully specific for ECs. Indeed, the Tek-Cre was previously reported to cause germline recombination, particularly in females,34 and to be expressed in some hematopoietic cells, including macrophages.36 Although recent data have recognized the yolk sac rather than the bone marrow origin of KCs and many other resident tissue macrophages under homeostatic conditions, yolk sac progenitors also transiently express the Tek receptor tyrosine kinase.33 We therefore carefully evaluated the specificity of the Tek-Cre in our models using Cre reporter mice and Bmp6 genomic DNA and RNA expression analysis. Germline recombination was detected in 30% to 100% of offspring from female Tek-Cre mice; however, no germline recombination was seen in offspring from Tek-Cre male mice, which were therefore used for subsequent analysis. Interestingly, tdT expression and Bmp6 recombination was seen not only in ECs but also in KCs from Rosa26tdT;Tek-Cre+ and Bmp6fl/fl;Tek-Cre+ mice. The activity of Tek-Cre in KCs and most likely other resident tissue macrophages should therefore be taken into account in future studies using this Cre strain. Importantly, the lack of iron phenotype in Bmp6fl/fl;LysM-Cre+ mice, in which Cre-mediated recombination also occurs in KCs and other myeloid cells,30,32 effectively rules out a major role for these cell types in Bmp6 production for hepcidin regulation. A major role for hepatocytes is also excluded by the absence of iron overload in Bmp6fl/fl;Alb-Cre+ mice.
Our data not only exclude a major functional role for KCs and hepatocytes in Bmp6 production for iron homeostasis regulation, but also suggest that hepatocytes and KCs do not produce Bmp6. This provides an important clarification to the literature in which gradient ultracentrifugation and magnetic-activated cell sorting have been used to isolate ∼95% pure liver cell populations, wherein Bmp6 mRNA levels were only ∼3- to 20-fold higher in ECs compared with KCs,22-24 and Bmp6 mRNA seemed to be upregulated by iron in most liver cell types.23,24 Moreover, iron-inducible Bmp6 protein expression was previously reported in hepatocytes by immunohistochemistry.19,25 In this study, we achieved a greater purity (≥99%) of KCs and ECs using a FACS-based method, which demonstrated ∼30- to 80-fold higher Bmp6 mRNA levels in isolated ECs than in KCs. Unexpectedly, Bmp6 mRNA levels were not further reduced in isolated KCs of Bmp6fl/fl;LysM-Cre+ mice or in hepatocytes of Bmp6fl/fl;Alb-Cre+ mice, even in the context of iron loading. This was not the result of inefficient Cre-mediated recombination because abundant tdT fluorescence was seen in the expected cell type in Cre-reporter mice. Moreover, loss of the floxed Bmp6 allele and the presence of recombined Bmp6 allele were clearly detected in the expected cell type by PCR of genomic DNA. Importantly, the relative expression level of Bmp6 in isolated ECs compared with KCs and hepatocytes closely mirrored the relative expression level of the EC-specific marker Cd146 in each cell fraction. Moreover, Bmp6 mRNA was significantly reduced in all liver cell types of Bmp6fl/fl;Tek-Cre+ mice despite no evidence of Tek-Cre activity in hepatocytes in Cre-reporter mice or genomic DNA evaluation, in which EC contamination would be less evident because of smaller variations in DNA expression among cell types. Together, these data suggest that hepatocytes and KCs do not express Bmp6 and that the Bmp6 detected in isolated KCs and hepatocytes in our study and described in prior publications22-24 is most likely the result of EC contamination. Because Bmp6 mRNA is much more abundant in ECs than other liver cell types, even a small contamination (∼1%) could have a disproportionate effect. The findings of iron-inducible Bmp6 protein expression in hepatocytes previously reported by immunohistochemistry19,25 may be a consequence of nonspecific antibody binding (which was reported with the same antibodies in immunoblot assays),19,21 or these assays may detect secreted Bmp6 protein released from ECs that has bound to Hjv and the Bmp receptor complex in hepatocytes.
A predominant role for ECs, but not hepatocytes or KCs, in liver BMP6 production is consistent with the strong reduction in total liver Bmp6 mRNA expression in Bmp6fl/fl;Tek-Cre+, but not Bmp6fl/fl;Alb-Cre+ or Bmp6fl/fl;LysM-Cre+ mice. However, Bmp6fl/fl;Tek-Cre+ mice still had detectable liver Bmp6 mRNA, whereas Bmp6−/− mice did not. This is likely due, at least in part, to incomplete efficiency of Cre-mediated recombination in ECs, since low Bmp6 levels were still detectable in isolated ECs of Bmp6fl/fl;Tek-Cre+ mice. Another liver cell type, possibly HSCs, could also have a minor contributory role in Bmp6 production. This residual liver Bmp6 expression in Bmp6fl/fl;Tek-Cre+ mice, but not Bmp6−/− mice, most likely explains the phenotype differences between mice. Although they exhibited similar degrees of serum and liver iron overload, Bmp6fl/fl;Tek-Cre+ mice tended to have higher Hamp mRNA, particularly in males, and reduced extrahepatic iron loading compared with sex-matched Bmp6−/− mice. In extrahepatic tissues, heart was loaded later and to a lesser degree than pancreas. A similar but more pronounced pattern of increased Hamp mRNA and less extrahepatic iron loading was also seen in female compared with male Bmp6−/− and Bmp6fl/fl;Tek-Cre+ mice. This sex-related dimorphism is consistent with that in a prior study in Bmp6−/− mice attributed to the Hamp-suppressive effects of testosterone.35 The authors postulated that lower hepcidin levels in male Bmp6−/− mice allowed a greater or faster accumulation of nontransferrin-bound iron available for uptake by extrahepatic tissues.35 Differential kinetics of iron uptake in liver and extrahepatic tissues, with a threshold behavior for extrahepatic loading with respect to liver iron concentration and earlier loading in pancreas compared with heart, has been well described in thalassemia patients.37-39
The data from the Bmp6fl/fl;Tek-Cre mice do not exclude a role for Bmp6 production from extrahepatic ECs in hepcidin regulation. However, Bmp6 mRNA seems to be regulated by iron exclusively in the liver.18-21 Indeed, Bmp6 expression in spleen18 and heart is not induced by a high iron diet. The ability of iron to upregulate intestinal Bmp6 expression reported in 1 study40 was not corroborated in numerous other studies,18-21 and the specificity of the Bmp6 antibody in the original study40 has been questioned.19,21 Moreover, circulating Bmp6 levels are extremely low.21 Thus, Bmp6 is most likely functioning locally in the liver to regulate hepcidin.
Our data suggest a model in which liver SECs produce BMP6, which has paracrine actions on the co-receptor HJV in hepatocytes to regulate hepcidin production (Figure 6B). Although HJV binds BMP6 with high affinity and is well-established to augment BMP6 induction of hepcidin expression,14,41,42 HJV is not required for BMP6 signaling or hepcidin regulation.42-44 Indeed, BMP6 still induces hepcidin in Hjv−/− primary hepatocytes, albeit to a lesser degree than in wild-type hepatocytes.42 Moreover, hepcidin is still inducible by iron to some extent in Hjv−/− mice.43 This raises the possibility that BMP6 could regulate hepcidin independent of HJV, at least when HJV is unavailable; however, there is no evidence that BMP6 regulates hepcidin independent of HJV under normal conditions.
In summary, our findings reveal a crucial role for ECs in the production of BMP6 for hepcidin and iron homeostasis regulation. Another liver cell population, possibly HSCs, may also have a minor role. However, our data exclude a major role for hepatocytes and KCs in BMP6 production and expose the limitations of liver cell isolation protocols. These findings are a critical step toward understanding the complex regulatory network by which iron levels are sensed by the liver to regulate hepcidin production and how this process goes awry in iron homeostasis disorders.
The online version of this article contains a data supplement.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.
The authors thank Dennis Brown, Nicolas Da Silva, and Leileata Russo for helpful discussions and Abraham Bayer for technical assistance with immunofluorescence assays.
This work was supported by National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases grants RO1-DK087727 (J.L.B.) and T32 DK007540 (K.B.Z.B. and A.B.C.), and a Howard Goodman Fellowship Award from the Massachusetts General Hospital (J.L.B.). NIH Shared Instrumentation Grant S10 RR031563 funded the purchase of the Nikon A1R confocal confocal laser scanning microscope. The Boston Area Diabetes and Endocrinology Research Center (DK57521) and the Massachusetts General Hospital Center for the Study of Inflammatory Bowel Disease (DK43351) provided additional support for the Program in Membrane Biology Microscopy Core.
Contribution: S.C. performed experiments, interpreted data, and wrote the paper; K.B.Z.-B. initiated the generation of the Bmp6 floxed, global, and conditional knockout mice; A.B.C. helped with mouse studies and performed immunofluorescence microscopy; C.-Y.W. helped with mouse studies; R.B. helped with immunofluorescence microscopy; M.N. and F.K.S. assisted with fluorescence-activated cell sorting experiments, and J.L.B. conceived and oversaw the study, interpreted data, and wrote the paper.
Conflict-of-interest disclosure: J.L.B. has ownership interest in Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital on the basis of work cited here and in prior publications. The remaining authors declare no competing financial interests.
Correspondence: Jodie L. Babitt, Massachusetts General Hospital, 185 Cambridge St, CPZN-8208, Boston, MA 02114; e-mail: firstname.lastname@example.org.